Abstract

Objective: This study aims to identify facilitators and barriers of Human Papillomavirus (HPV) vaccine acceptance, initiation, and completion among LGBTQ (lesbian, gay, bisexual, trans, and queer) individuals. Method: A systematic review of qualitative and quantitative studies on HPV vaccine acceptance, initiation, and completion from 2006 to June 15, 2020 was performed in each database. Results: Twenty-six studies focusing on HPV vaccination among LGBTQ individuals were reviewed. Conclusions: Knowledge of HPV vaccine and healthcare providers’ recommendations were identified as facilitators to receive HPV vaccinate, while high co-pay cost and concerns of the effectiveness and safety were identified as barriers.

 抽象的

目的：本研究旨在确定 LGBTQ（女同性恋、男同性恋、双性恋、跨性别者和酷儿）个体接受、启动和完成人乳头瘤病毒 (HPV) 疫苗的促进因素和障碍。方法：对每个数据库中 2006 年至 2020 年 6 月 15 日期间 HPV 疫苗接受、启动和完成的定性和定量研究进行系统回顾。结果：对 26 项关注 LGBTQ 人群 HPV 疫苗接种的研究进行了回顾。结论： HPV 疫苗知识和医疗保健提供者的建议被认为是接受 HPV 疫苗接种的促进因素，而高额自付费用以及对有效性和安全性的担忧被认为是障碍。